相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Vitamin C promotes the proliferation and effector functions of human γδ T cells
Leonce Kouakanou et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
The increased IL-17-producing γδT cells promote tumor cell proliferation and migration in neuroblastoma
Hui Zhang et al.
CLINICAL IMMUNOLOGY (2020)
Vδ2 T cell subsets, defined by PD-1 and TIM-3 expression, present varied cytokine responses in acute myeloid leukemia patients
Kangni Wu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
The human fetal thymus generates invariant effector γδ T cells
Paola Tieppo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
A population of proinflammatory T cells coexpresses αβ and γδ T cell receptors in mice and humans
Sarah C. Edwards et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Pitfalls in the characterization of circulating and tissue-resident human γδ T cells
Nicola Beucke et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
TCR repertoire analysis reveals phosphoantigen-induced polyclonal proliferation of Vγ9Vδ2 T cells in neonates and adults
Alina S. Fichtner et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
Resolving the mystery-How TCR transgenic mouse models shed light on the elusive case of gamma delta T cells
Anne M. Hahn et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells
Marc Rigau et al.
SCIENCE (2020)
γδ T-cell Receptors Derived from Breast Cancer-Infiltrating T Lymphocytes Mediate Antitumor Reactivity
Anke Janssen et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Systemic β-Adrenergic Receptor Activation Augments the ex vivo Expansion and Anti-Tumor Activity of Vγ9Vδ2 T-Cells
Forrest L. Baker et al.
FRONTIERS IN IMMUNOLOGY (2020)
Suppressive activity of Vδ2+ γδ T cells on αβ T cells is licensed by TCR signaling and correlates with signal strength
Karin Schilbach et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Broad Cytotoxic Targeting of Acute Myeloid Leukemia by Polyclonal Delta One T Cells
Biagio Di Lorenzo et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Allogenic V9V2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma
Mohammed Alnaggar et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
IL-21-mediated expansion of Vγ9Vδ2 T cells is limited by the Tim-3 pathway
Kangni Wu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model
Jaquelyn T. Zoine et al.
ONCOIMMUNOLOGY (2019)
IL-7-dependent compositional changes within the γδ T cell pool in lymph nodes during ageing lead to an unbalanced anti-tumour response
Hung-Chang Chen et al.
EMBO REPORTS (2019)
Preservation of cell-based immunotherapies for clinical trials
Rui Li et al.
CYTOTHERAPY (2019)
TCR Sequencing Reveals the Distinct Development of Fetal and Adult Human Vγ9Vδ2 T Cells
Maria Papadopoulou et al.
JOURNAL OF IMMUNOLOGY (2019)
Engineering γδT cells limits tonic signaling associated with chimeric antigen receptors
Jonathan Fisher et al.
SCIENCE SIGNALING (2019)
TGF-β enhances the cytotoxic activity of Vδ2 T cells
Christian Peters et al.
ONCOIMMUNOLOGY (2019)
Optimized protocols for T cell expansion and lentiviral transduction
Rui-Ning Wang et al.
MOLECULAR MEDICINE REPORTS (2019)
γδ TCR ligands: the quest to solve a 500-million-year-old mystery
Benjamin E. Willcox et al.
NATURE IMMUNOLOGY (2019)
Early Reconstitution of NK and gamma delta T Cells and Its Implication for the Design of Post-Transplant Immunotherapy
Moniek A. de Witte et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells
Lin Xiao et al.
CYTOTHERAPY (2018)
Human Vδ3+ γδ T cells induce maturation and IgM secretion by B cells
Andreea Petrasca et al.
IMMUNOLOGY LETTERS (2018)
Gamma-delta (γδ) T cells: friend or foe in cancer development?
Yijing Zhao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation
Anna Capsomidis et al.
MOLECULAR THERAPY (2018)
gamma delta T cell responses: How many ligands will it take till we know?
David Vermijlen et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)
Butyrophilin3A proteins and V gamma 9V delta 2 T cell activation
Siyi Gu et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)
The human Vδ2+ T-cell compartment comprises distinct innate-like Vγ9+ and adaptive Vγ9- subsets
Martin S. Davey et al.
NATURE COMMUNICATIONS (2018)
Expansion of Gammadelta T Cells from Cord Blood: A Therapeutical Possibility
Sofia Berglund et al.
STEM CELLS INTERNATIONAL (2018)
Improving the Efficiency of Vγ9Vδ2 T Cell Immunotherapy in Cancer
Timm Hoeres et al.
FRONTIERS IN IMMUNOLOGY (2018)
Engineering Approaches in Human Gamma Delta T Cells for Cancer Immunotherapy
Jonathan Fisher et al.
FRONTIERS IN IMMUNOLOGY (2018)
Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells
Hans H. Oberg et al.
FRONTIERS IN IMMUNOLOGY (2018)
Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local
C. David Pauza et al.
FRONTIERS IN IMMUNOLOGY (2018)
New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity
Juan-Luis Blazquez et al.
FRONTIERS IN IMMUNOLOGY (2018)
The gamma delta TCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness
Daisy Melandri et al.
NATURE IMMUNOLOGY (2018)
Integrating Vectors for Gene Therapy and Clonal Tracking of Engineered Hematopoiesis
Luca Biasco et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2017)
Interleukin-7 Availability Is Maintained by a Hematopoietic Cytokine Sink Comprising Innate Lymphoid Cells and T Cells
Christopher E. Martin et al.
IMMUNITY (2017)
Integration of a CD19 CAR into the. TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells
Daniel T. MacLeod et al.
MOLECULAR THERAPY (2017)
Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen Receptor
Jonathan Fisher et al.
MOLECULAR THERAPY (2017)
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem et al.
NATURE (2017)
Sterile protection against human malaria by chemoattenuated PfSPZ vaccine
Benjamin Mordmueller et al.
NATURE (2017)
The Ambiguous Role of γδ T Lymphocytes in Antitumor Immunity
Guranda Chitadze et al.
TRENDS IN IMMUNOLOGY (2017)
Clonal selection in the human Vδ1 T cell repertoire indicates γδ TCR-dependent adaptive immune surveillance
Martin S. Davey et al.
NATURE COMMUNICATIONS (2017)
Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications
Myriam Lawand et al.
FRONTIERS IN IMMUNOLOGY (2017)
Zoledronic acid boosts γδ T-cell activity in children receiving αβ+ T and CD19+ cell-depleted grafts from an HLA-haplo-identical donor
A. Bertaina et al.
ONCOIMMUNOLOGY (2017)
Global Manufacturing of CAR T Cell Therapy
Bruce L. Levine et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Enhancing adoptive cancer immunotherapy with VΥ2Vδ2 T cells through pulse zoledronate stimulation
Mohanad H. Nada et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma
Dennis C. Harrer et al.
BMC CANCER (2017)
Adoptively transferred Vγ9Vδ2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model
Nicholas A. Zumwalde et al.
JCI INSIGHT (2017)
MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue
Hormas Ghadially et al.
BRITISH JOURNAL OF CANCER (2017)
Nano-technology based carriers for nitrogen-containing bisphosphonates delivery as sensitisers of γδ T cells for anticancer immunotherapy
Naomi O. Hodgins et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection
Sarina Ravens et al.
NATURE IMMUNOLOGY (2017)
Delta One T Cells for Immunotherapy of Chronic Lymphocytic Leukemia: Clinical-Grade Expansion/Differentiation and Preclinical Proof of Concept
Afonso R. Almeida et al.
CLINICAL CANCER RESEARCH (2016)
Bisphosphonates: Pharmacokinetics, bioavailability, mechanisms of action, clinical applications in children, and effects on tooth development
Ana Prates Soares et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2016)
Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells
Heleen H. Van Acker et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Improved analysis of TCRγδ variable region expression in humans
Petros Christopoulos et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2016)
Ionic immune suppression within the tumour microenvironment limits T cell effector function
Robert Eil et al.
NATURE (2016)
IFNγ-Dependent Interactions between ICAM-1 and LFA-1 Counteract Prostaglandin E2-Mediated Inhibition of Antitumor CTL Responses
Fatemah Salem Basingab et al.
CANCER IMMUNOLOGY RESEARCH (2016)
γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes
Irma Airoldi et al.
BLOOD (2015)
The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy
Mateusz Legut et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Human gamma delta T cells: Evolution and ligand recognition
Erin J. Adams et al.
CELLULAR IMMUNOLOGY (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and γδT Cells
Kanako Shimizu et al.
PLOS ONE (2015)
The Role of Gamma Delta T Cells in Haematopoietic Stem Cell Transplantation
L. Minculescu et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2015)
Sensing of pyrophosphate metabolites by Vγ9δ2T cells
Siyi Gu et al.
FRONTIERS IN IMMUNOLOGY (2015)
Ex vivo expanded human circulating Vδ1 γδT cells exhibit favorable therapeutic potential for colon cancer
Dang Wu et al.
ONCOIMMUNOLOGY (2015)
Opportunities and challenges in development of phosphoantigens as Vγ9Vδ2 T cell agonists
David F. Wiemer et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Novel Bispecific Antibodies Increase γδ T-Cell Cytotoxicity against Pancreatic Cancer Cells
Hans-Heinrich Oberg et al.
CANCER RESEARCH (2014)
Neuroblastoma Killing Properties of Vδ2 and Vδ2-Negative γδT Cells Following Expansion by Artificial Antigen-Presenting Cells
Jonathan P. H. Fisher et al.
CLINICAL CANCER RESEARCH (2014)
The TCR γδ Repertoire and Relative Gene Expression Characteristics of T-ALL Cases with Biclonal Malignant Vδ1 and Vδ2 T Cells
Haitao Zheng et al.
DNA AND CELL BIOLOGY (2014)
The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells
Andrew Sandstrom et al.
IMMUNITY (2014)
gamma delta T Cells and Their Potential for Immunotherapy
Yan-Ling Wu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
The molecular bases of δ/αβ T cell-mediated antigen recognition
Daniel G. Pellicci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
A Novel T Cell Subset with Trans-Rearranged Vγ-Cβb TCRs Shows Vβ Expression Is Dispensable for Lineage Choice and MHC Restriction
Steven Bowen et al.
JOURNAL OF IMMUNOLOGY (2014)
Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells
Martin Wilhelm et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
Gregory L. Beatty et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer
Ikuo Wada et al.
CANCER MEDICINE (2014)
Human peripheral CD4+ Vδ1+ γδT cells can develop into αβT cells
Hendrik Ziegler et al.
FRONTIERS IN IMMUNOLOGY (2014)
gamma delta T cells for cancer immunotherapy A systematic review of clinical trials
Jonathan P. H. Fisher et al.
ONCOIMMUNOLOGY (2014)
Extensive expansion of primary human gamma delta T cells generates cytotoxic effector memory cells that can be labeled with Feraheme for cellular MRI
Gabrielle M. Siegers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
What lessons can be learned from γδ T cell-based cancer immunotherapy trials?
Jean-Jacques Fournie et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain
Takamichi Izumi et al.
CYTOTHERAPY (2013)
The Inhibitory Receptor BTLA Controls γδ T Cell Homeostasis and Inflammatory Responses
Vasileios Bekiaris et al.
IMMUNITY (2013)
Early IL-17 Production by Intrahepatic T Cells Is Important for Adaptive Immune Responses in Viral Hepatitis
Lifei Hou et al.
JOURNAL OF IMMUNOLOGY (2013)
Bispecific T-cells Expressing Polyclonal Repertoire of Endogenous γδ T-cell Receptors and Introduced CD19-specific Chimeric Antigen Receptor
Drew C. Deniger et al.
MOLECULAR THERAPY (2013)
Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells
Stefano Vavassori et al.
NATURE IMMUNOLOGY (2013)
Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy
Lawrence S. Lamb et al.
PLOS ONE (2013)
Six-of-the-best: unique contributions of γδ T cells to immunology
Pierre Vantourout et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Antibody-dependent anti-cytomegalovirus activity of human γδ T cells expressing CD16 (FcγRIIIa)
Lionel Couzi et al.
BLOOD (2012)
Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset
Christelle Harly et al.
BLOOD (2012)
The Molecular Basis for Modulation of Human Vγ9Vδ2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific Antibodies
Aparna Palakodeti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Tumor-promoting Versus Tumor-antagonizing Roles of γδ T Cells in Cancer Immunotherapy: Results From a Prospective Phase I/II Trial
Volker Kunzmann et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Complex Role of γδ T-Cell-Derived Cytokines and Growth Factors in Cancer
Andrew G. Ramstead et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2012)
Interleukin 7 (IL-7) selectively promotes mouse and human IL-17-producing γδ cells
Marie-Laure Michel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC-MS/MS
Linda Henneman et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2011)
Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
A. J. Nicol et al.
BRITISH JOURNAL OF CANCER (2011)
Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
Joshua M. Lang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Zoledronate-activated V gamma 9 gamma delta T cell-based immunotherapy is feasible and restores the impairment of gamma delta T cells in patients with solid tumors
Atsutaka Noguchi et al.
CYTOTHERAPY (2011)
Vδ1 γδ T cells as a potential new approach to T-cell immunotherapy in patients with chronic lymphocytic leukemia
[Anonymous]
IMMUNOTHERAPY (2011)
The Sleeping Beauty transposon system: a non-viral vector for gene therapy
Elena L. Aronovich et al.
HUMAN MOLECULAR GENETICS (2011)
Cutaneous immunosurveillance by self-renewing dermal γδ T cells
Nital Sumaria et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Stimulated γδ T Cells Increase the In Vivo Efficacy of Trastuzumab in HER-2+ Breast Cancer
Aude-Helene Capietto et al.
JOURNAL OF IMMUNOLOGY (2011)
Adoptive Immunotherapy for Advanced Non-small Cell Lung Cancer Using Zoledronate-expanded γδ T Cells: A Phase I Clinical Study
Miki Sakamoto et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Zoledronic Acid Induces Autophagic Cell Death in Human Prostate Cancer Cells
Ji-Fan Lin et al.
JOURNAL OF UROLOGY (2011)
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
Michael Gnant et al.
LANCET ONCOLOGY (2011)
Human Vδ1 γδT cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells
Gabrielle M. Siegers et al.
CYTOTHERAPY (2011)
In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients
S. Meraviglia et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells
Jun Nakajima et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2010)
Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound
Jonathan R. Green et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Phosphoantigens Overcome Human TCRVγ9+ γδ Cell Immunosuppression by TGF-β: Relevance for Cancer Immunotherapy
Aude-Helene Capietto et al.
JOURNAL OF IMMUNOLOGY (2010)
Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial
Rebecca Aft et al.
LANCET ONCOLOGY (2010)
Preferential Th1 Cytokine Profile of Phosphoantigen-Stimulated Human V gamma 9V delta 2T Cells
Margaret R. Dunne et al.
MEDIATORS OF INFLAMMATION (2010)
Adoptive immunotherapy of lung cancer with immobilized anti-TCRγδ antibody-expanded human γδ T-cells in peripheral blood
Ning Kang et al.
CANCER BIOLOGY & THERAPY (2009)
IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human Vγ9Vδ2 T Cells for Adoptive Immunotherapy
Aurelie Thedrez et al.
JOURNAL OF IMMUNOLOGY (2009)
Self-inactivating Retroviral Vector-mediated Gene Transfer Induces Oncogene Activation and Immortalization of Primary Murine Bone Marrow Cells
Marita Bosticardo et al.
MOLECULAR THERAPY (2009)
Phase I/II Study of IPH1101, γσ T Cell Agonist, Combined with Rituximab, in Low Grade Follicular Lymphoma Patients.
Guy Laurent et al.
BLOOD (2009)
Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Isopentenyl pyrophosphate-activated CD516+ γδ T lymphocytes display potent antitumor activity toward human squamous cell carcinoma
Alan A. Z. Alexander et al.
CLINICAL CANCER RESEARCH (2008)
TCR-β chains derived from peripheral γδ T cells can take part in αβ T-cell development
Nabil Bosco et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Dysregulation of the host mevalonate pathway during early bacterial infection activates human TCR γδ cells
Magdalena Kistowska et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vγ9Vδ2 T cells from renal cell carcinoma patients
Emilie Viey et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
Francesco Dieli et al.
CANCER RESEARCH (2007)
Distinct cytokine-driven responses of activated blood γδ T cells:: Insights into unconventional T cell pleiotropy
David Vermijlen et al.
JOURNAL OF IMMUNOLOGY (2007)
Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
The Bloom's syndrome helicase is critical for development and function of the αβ T-cell lineage
Holger Babbe et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Combination immunotherapy with clinical-scale enriched human γδ T cells, hu14.18 antibody, and the immunocytokine Fc-IL7 in disseminated neuroblastoma
M Otto et al.
CLINICAL CANCER RESEARCH (2005)
Professional antigen-presentation function by human γδ T cells
M Brandes et al.
SCIENCE (2005)
Differential requirements for antigen or homeostatic cytokines for proliferation and differentiation of human Vγ9Vδ2 naive, memory and effector T cell subsets
N Caccamo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Shared reactivity of V δ2neg γδ T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells
F Halary et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Ex vivo expanded human Vγ9Vδ2+γδ-T cells mediate innate antitumor activity against human prostate cancer cells in vitro
ZY Liu et al.
JOURNAL OF UROLOGY (2005)
γδ T cell homeostasis is controlled by IL-7 and IL-15 together with subset-specific factors
R Baccala et al.
JOURNAL OF IMMUNOLOGY (2005)
γδ T cells:: A new frontier for immunotherapy?
LS Lamb et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Epithelial defence by gamma delta T cells
D Kabelitz et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2005)
Human γδ T cells as mediators of chimaeric-receptor redirected anti-tumour immunity
M Rischer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
γδ T cells for immune therapy of patients with lymphoid malignancies
M Wilhelm et al.
BLOOD (2003)
Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells
HJ Gober et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Differentiation of human γδ T cells towards distinct memory phenotypes
M Eberl et al.
CELLULAR IMMUNOLOGY (2002)
Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human γδ T cells in Escherichia coli
M Hintz et al.
FEBS LETTERS (2001)
Differentiation of resting human peripheral blood γδ T cells toward Th1-or Th2-phenotype
D Wesch et al.
CELLULAR IMMUNOLOGY (2001)
Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck - A phase 1 study
WC To et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2000)